Cellular and T cell engager Immunotherapy
Effectiveness and safety of teclistamab in triple-class exposed relapsed/refractory multiple myeloma: results of the French real-world RetrosTECtive study.
Aurore Perrot, MD, PhD
Professor
CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France, Midi-Pyrenees, France